Isodose moderately hypofractionated radiotherapy allows patients to undergo just 4-5 weeks of treatment, compared to conventional therapy that can take around 8. 

Trial results thus far indicate the drug can significantly extend progression-free survival compared to current standard of care treatments.

By giving providers greater insight into a tumor’s molecular footprint, the method could also reduce the need for invasive biopsies.

New findings related to Vesical Imaging-Reporting and Data System scores and specific MRI findings could improve the management of bladder cancer. 

This is a collection of radiology imaging showing various presentations of thyroid nodules.

These animals are virtually indestructible and have long outlived the dinosaurs due to their ability to withstand extreme cold, heat, natural disasters and even cosmic radiation.

The less invasive method could help men avoid some of the unpleasant side effects such as urinary incontinence and sexual dysfunction, which are known deterrents for patients facing potential prostatectomy.

New findings indicate as many as 96% of men with positive PSA labs who show insignificant or slow-growing cancer on MRI can safely forego biopsy for three or more years.